Antibiotics for the Treatment of COVID-19
Gespeichert in:
Veröffentlicht in: | American family physician 2022-03, Vol.105 (3), p.237-238 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 238 |
---|---|
container_issue | 3 |
container_start_page | 237 |
container_title | American family physician |
container_volume | 105 |
creator | Crawford-Faucher, Amy |
description | |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2639228081</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638946402</sourcerecordid><originalsourceid>FETCH-LOGICAL-p154t-65870cb33cd1963b3bdeb9995843817328a32dd760e5a4f1432be164808e1be53</originalsourceid><addsrcrecordid>eNpd0MFLwzAUBvAgipvTf0EKXvQQSPKSNDmO6nQw2GWKt9K0r9jRNrVJD_73VpwXT48Pfnx8vDOy5AoEZVqxc7JkjAlqwLwvyFUIxzmmittLsgAljFWaL8nDuo-Na3xsypDUfkziByaHEYvYYR8TXyfZ_m37SLm9Jhd10Qa8Od0Ved08HbIXuts_b7P1jg5cyUi1MikrHUBZcavBgavQWWuVkWB4CsIUIKoq1QxVIWsuQTjkWhpmkDtUsCL3v73D6D8nDDHvmlBi2xY9-inkQoMVYuZ8pnf_6NFPYz-v-1HGSi2ZmNXtSU2uwyofxqYrxq_87wnwDVEgVPQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638946402</pqid></control><display><type>article</type><title>Antibiotics for the Treatment of COVID-19</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Crawford-Faucher, Amy</creator><creatorcontrib>Crawford-Faucher, Amy</creatorcontrib><identifier>ISSN: 0002-838X</identifier><identifier>EISSN: 1532-0650</identifier><identifier>PMID: 35289561</identifier><language>eng</language><publisher>United States: American Academy of Family Physicians</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Asymptomatic ; Azithromycin - therapeutic use ; Cardiac arrhythmia ; Coronaviruses ; COVID-19 ; COVID-19 - drug therapy ; COVID-19 - mortality ; Humans ; Mortality ; Pandemics ; Patients ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>American family physician, 2022-03, Vol.105 (3), p.237-238</ispartof><rights>Copyright American Academy of Family Physicians Mar 01, 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35289561$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crawford-Faucher, Amy</creatorcontrib><title>Antibiotics for the Treatment of COVID-19</title><title>American family physician</title><addtitle>Am Fam Physician</addtitle><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Asymptomatic</subject><subject>Azithromycin - therapeutic use</subject><subject>Cardiac arrhythmia</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - drug therapy</subject><subject>COVID-19 - mortality</subject><subject>Humans</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0002-838X</issn><issn>1532-0650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpd0MFLwzAUBvAgipvTf0EKXvQQSPKSNDmO6nQw2GWKt9K0r9jRNrVJD_73VpwXT48Pfnx8vDOy5AoEZVqxc7JkjAlqwLwvyFUIxzmmittLsgAljFWaL8nDuo-Na3xsypDUfkziByaHEYvYYR8TXyfZ_m37SLm9Jhd10Qa8Od0Ved08HbIXuts_b7P1jg5cyUi1MikrHUBZcavBgavQWWuVkWB4CsIUIKoq1QxVIWsuQTjkWhpmkDtUsCL3v73D6D8nDDHvmlBi2xY9-inkQoMVYuZ8pnf_6NFPYz-v-1HGSi2ZmNXtSU2uwyofxqYrxq_87wnwDVEgVPQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Crawford-Faucher, Amy</creator><general>American Academy of Family Physicians</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20220301</creationdate><title>Antibiotics for the Treatment of COVID-19</title><author>Crawford-Faucher, Amy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p154t-65870cb33cd1963b3bdeb9995843817328a32dd760e5a4f1432be164808e1be53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Asymptomatic</topic><topic>Azithromycin - therapeutic use</topic><topic>Cardiac arrhythmia</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - drug therapy</topic><topic>COVID-19 - mortality</topic><topic>Humans</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crawford-Faucher, Amy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crawford-Faucher, Amy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotics for the Treatment of COVID-19</atitle><jtitle>American family physician</jtitle><addtitle>Am Fam Physician</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>105</volume><issue>3</issue><spage>237</spage><epage>238</epage><pages>237-238</pages><issn>0002-838X</issn><eissn>1532-0650</eissn><cop>United States</cop><pub>American Academy of Family Physicians</pub><pmid>35289561</pmid><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-838X |
ispartof | American family physician, 2022-03, Vol.105 (3), p.237-238 |
issn | 0002-838X 1532-0650 |
language | eng |
recordid | cdi_proquest_miscellaneous_2639228081 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Anti-Bacterial Agents - therapeutic use Antibiotics Asymptomatic Azithromycin - therapeutic use Cardiac arrhythmia Coronaviruses COVID-19 COVID-19 - drug therapy COVID-19 - mortality Humans Mortality Pandemics Patients Severe acute respiratory syndrome coronavirus 2 |
title | Antibiotics for the Treatment of COVID-19 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A52%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotics%20for%20the%20Treatment%20of%20COVID-19&rft.jtitle=American%20family%20physician&rft.au=Crawford-Faucher,%20Amy&rft.date=2022-03-01&rft.volume=105&rft.issue=3&rft.spage=237&rft.epage=238&rft.pages=237-238&rft.issn=0002-838X&rft.eissn=1532-0650&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2638946402%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638946402&rft_id=info:pmid/35289561&rfr_iscdi=true |